2King PT. The pathophysiology of bronchiectasis[J].Int J Chron Obstruct Pulmon Dis,2009.411-419.
3Patel IS,Vlahos I,Wilkinson TM. Bronchiectasis,exacerbation indices and inflammation in chronic obstructive pulmonary disease[J].American Journal of Respiratory and Critical Care Medicine,2004,(04):400-407.
4Evans SA,Turner SM,Bosch BJ. Lung function in bron chiectasis:the influence of Pseudomonas aeruginosa[J].European Respiratory Journal,1996,(08):1601-1604.
5Kim JS,Müller NL,Park CS. Bronchoarterial ratio on thin section CT:comparison between high altitude and sea level[J].Journal of Computer Assisted Tomography,1997,(02):306-311.
6Woodring JH. Improved plain film criteria for the diagnosis of bronchiectasis[J].JOURNAL OF THE KENTUCKY MEDICAL ASSOCIATION,1994,(01):8-13.
7O'Neill B,Bradley JM,McArdle N. The current physiotherapy management of patients with bronchiectasis:a UK survey[J].International Journal of Clinical Practice,2002,(01):34-35.
8Kellett F,Redfern J,Niven RM. Evaluation of nebulised hypertonic saline(7 %)as an adjunct to physiotherapy in patients with stable bronchiectasis[J].Respiratory Medicine,2005,(01):27-31.
二级参考文献18
1Woodhead M, Blasi F, Ewig S, et al. European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J,2005,26 : 1138-1180.
2Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections - - full version. Clin Microbiol Infect, 2011, 17 Suppl 6: El-E59.
3Pasteur MC, Bilton D, Hill AT, et al. British Thoracic Society guideline for non-CF bronchiectasis. Thorax,2010,65 Suppl 1 :i1- 58.
4Weycker D, Edelsberg J, Oster G, et al. Prevalence and economic burden of bronchiectasis. Am J Respir Cfit Care Med, 2004,169 : A330.
5Twiss J, Metcalfe R, Edwards E, et al. New Zealand national incidence of bronchiectasis "too high" for a developed country. Arch Dis Child,2005, 90:737-740.
6Weycker D, Edelsberg J, Oster G, et al. Prevalence and economic burden of bronchiectasis. Clin Pulm M ed,2005,12:205- 209.
7Crofton J. Bronchiectasis. In: Cmflon J, Douglas A, eds. Respiratory diseases. 3 rd eds. Oxford: Blackwell Scientific, 1981:417-430.
8Patel IS, Vlahos I, Wilkinson TM, et al. Bronchiectasis, exacerbation indices and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2004,70 : 400- 407.
9O'Brien C, Guest PJ, Hill SL, et al. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax, 2000,55 : 635-642.
10King PT. The pathophysiology of bronchiectasis. Int J Chron Obstruct Pulmon Dis, 2009,4 : 411-419.
5Shigemura N,Wan IY, Yu SC, et al. Multidiscipliaary ma- nagement of life-threatening massive hemoptysis: a 10 year experience. Ann Thorac Sury, 2009,87 (3) :849-853.
6van Kralingen KW, van Kralingen Heijboer AC, Zimmerman M, et al. Management of hemoptysis in a Third World city hospital: a retrospective study. Tuber Lung Dis,1995,76(4): 344-348.
